Literature DB >> 23018031

Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions.

Ping Xia1, Xu Fang, Zheng-hua Zhang, Qiong Huang, Ke-xiang Yan, Ke-fei Kang, Ling Han, Zhi-zhong Zheng.   

Abstract

Psoriasis is a common chronic inflammatory skin disorder with dysregulation of miRNAs. The expression pattern of miR-146a and target gene IRAK1 in lesions and PBMCs of plaque psoriasis remains unclear. In our study, we found the expression of miR-146a was up-regulated both in lesions and PBMCs of psoriatic patients, and positively correlated with IL-17 expression, whereas the target gene IRAK1 expression was expressed differentially in lesions and peripheral blood. Inability of miR-146a inhibiting target gene IRAK1 may contribute to the persistent inflammation in lesions of psoriasis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018031     DOI: 10.1016/j.imlet.2012.09.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  25 in total

1.  Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.

Authors:  Min Sun; Peizeng Yang; Yan Yang; Jian Ye
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

Review 2.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 3.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

4.  Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.

Authors:  Hung-Lin Chen; Chia-Hui Lo; Chi-Chun Huang; Meng-Ping Lu; Po-Yuan Hu; Chang-Shan Chen; Di-Yen Chueh; Peilin Chen; Teng-Nan Lin; Yuan-Hsin Lo; Yu-Ping Hsiao; Daniel K Hsu; Fu-Tong Liu
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

5.  Serum Levels of miR-146a in Patients with Psoriasis.

Authors:  Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M Silva; Manuela Selores; Paulo P Costa; Tiago Torres
Journal:  Mol Diagn Ther       Date:  2021-05-02       Impact factor: 4.074

6.  MicroRNA-146a represses mycobacteria-induced inflammatory response and facilitates bacterial replication via targeting IRAK-1 and TRAF-6.

Authors:  Shuo Li; Yan Yue; Wei Xu; Sidong Xiong
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

7.  MicroRNA-378a-3p is overexpressed in psoriasis and modulates cell cycle arrest in keratinocytes via targeting BMP2 gene.

Authors:  Wipasiri Soonthornchai; Pattarin Tangtanatakul; Kornvalee Meesilpavikkai; Virgil Dalm; Patipark Kueanjinda; Jongkonnee Wongpiyabovorn
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 8.  Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs.

Authors:  Deena Khan; S Ansar Ahmed
Journal:  Front Genet       Date:  2015-07-14       Impact factor: 4.599

Review 9.  Expression, regulation and function of microRNAs in multiple sclerosis.

Authors:  Xinting Ma; Juhua Zhou; Yin Zhong; Linlin Jiang; Ping Mu; Yanmin Li; Narendra Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Int J Med Sci       Date:  2014-06-02       Impact factor: 3.738

10.  A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study.

Authors:  Weigang Zhang; Xiuli Yi; Sen Guo; Qiong Shi; Chao Wei; Xia Li; Lin Gao; Gang Wang; Tianwen Gao; Lei Wang; Chunying Li
Journal:  J Cell Mol Med       Date:  2014-09-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.